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The H blood group system
E.A. Scharberg, C. Olsen, and P. Bugert
Revie w
The H blood group system, ISBT symbol H (018), consists of a 
single antigen (H) defined by a terminal fucose residue found 
on red blood cells and in secretions formed by the action 
of α-1,2-fucosyltransferases 1 (α2FucT1) and 2 (α2FucT2), 
respectively. Mutant alleles of the corresponding FUT1 and FUT2 
genes result in either a H– phenotype (Bombay phenotype, Oh) 
or a weak H phenotype (para-Bombay, H+w). In addition, the 
FUT2 gene is the molecular basis of the secretor (Se) status, 
and homozygosity or compound heterozygosity for null alleles 
is associated with the nonsecretor (se) status. H– individuals 
have natural anti-H (mostly IgM), which can cause severe 
hemolytic transfusion reactions with intravascular hemolysis. 
Immunohematology 2016;32:112–118.
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The H blood group system was discovered by Bhende et al.1 
in the early 1950s, when three individuals with a new unusual 
blood type were encountered in the city of Bombay (Mumbai) 
in India. The red blood cells (RBCs) of all three individuals 
typed as blood group O, but their serum samples were found to 
contain anti-A, anti-A1, anti-B, and anti-H and to agglutinate 
RBCs of all “ordinary” ABO groups.1 Their samples were 
serologically compatible only with the RBCs of one another 
and contained the first examples of potent human anti-H in 
individuals with RBCs that, based on tests with anti-A and 
anti-B, appeared to be homozygous for a “new” allelomorph 
at the A1 A2 B O locus.1 The phenotype was called Bombay 
phenotype. Further test results showed that the RBCs of these 
individuals did not react with human or animal anti-H sera. 
After the cloning and characterization of the FUT1 gene2 in 
1990 and proving that the gene was the molecular basis of the 
Bombay phenotype3 in 1994, the H blood group system was 
established.
This unusual blood group system has only one antigen 
(H). Complete lack of H is commonly known as the Bombay or 
Oh phenotype, and weak expression of H is referred to as the 
para-Bombay phenotype. The lack of H results in production 
of the corresponding naturally occurring antibodies, anti-A, 
anti-B, and anti-H.4,5
Biochemistry
The H antigen is a terminal fucose residue in an α-1,2-
linkage on precursor carbohydrate chains of two different 
types (Fig. 1). The H antigen on the type 1 precursor is 
predominantly produced by the α-1,2-fucosyltransferase 
2 (α2FucT2) enzyme in secretory cells of the digestive and 
respiratory tracts. The α-1,2-fucosyltransferase 1 (α2FucT1) 
enzyme is a single-pass type II transmembrane glycoprotein 
found in the Golgi apparatus that forms the H antigen on type 2 
precursor chains in erythroid tissues and vascular endothelial 
cells.6,7 The carbohydrate chain including the H antigen is then 
the substrate of the glycosyltransferases encoded by the ABO 
gene to produce A and/or B antigens. Subsequently, in blood 
group O individuals, the H antigen is not converted to A or B 
and is strongly detectable on RBCs.
H is found in highest amounts in group O individuals and 
in least amounts in group A, B, and AB individuals. This is 
because when the A and/or B enzymes are present, H antigen 
is converted to A and/or B antigen, resulting in less H antigen 
present on the cell membrane. H therefore varies in quantity 
according to the blood group as follows: O > A2 > B > A2B > 
A1 > A1B.
Antibodies in the H Blood Group System
Anti-H is the only antibody specificity found in the H 
blood group system. This antibody is naturally occurring in 
individuals who lack H, as is the case with ABO blood group 
antibodies. The serum of Oh individuals always contains 
anti-H, -A, and -B. Occasionally, A1, A1B, and (less commonly) 
B individuals expressing only a low quantity of H can produce 
anti-H, but the antibody is mostly weakly reactive and usually 
Fig. 1 Schematic illustration of the carbohydrate precursor chains 
used as substrates by the α2FucT1 and α2FucT2 enzymes encoded 
by the FUT1 and FUT2 genes, respectively. RBCs = red blood cells.
α2FucT2 α2FucT1
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considered clinically insignificant, unlike the anti-H in H– 
individuals, which can cause severe intravascular hemolysis.
Anti-H is most often type IgM, but it can have an IgG 
component. Like the isoagglutinins, it is best reactive by 
the saline room temperature method, but can also react in 
the indirect antiglobulin test (IAT), especially when an IgG 
component is present. Anti-H can activate complement, 
and is capable of causing intravascular hemolysis of RBCs. 
When anti-H is identified in pregnant women, tests using 
dithiothreitol can be performed to determine the presence or 
absence of IgG antibodies, and, if present, the titer of the IgG 
component.
Anti-H produced by Bombay phenotype individuals 
recognizes H on both type 1 (secretions) and type 2 (RBCs) 
chains, whereas the anti-H produced by Bombay secretors 
(hh, Se) reacts preferentially with type 2H. Anti-H lectin (Ulex 
europaeus) can be used to type individuals for the presence 
of H antigen. It is notable that the lectin reacts best with type 
2H individuals, but has some specificity for type 1H. There 
are other lectins (Lotus tetragonolobus, Anguilla anguilla, 
Cysticus sessifolius, and Laburnum alpinum) that recognize 
H antigen and also monoclonal antibodies with 1H and H 
specificity.
Autoanti-H and autoanti-IH are primarily autoantibodies 
that are encountered in a blood transfusion setting often in 
group A1 and B patients. These antibodies have been reported 
in individuals with cold agglutinin syndrome and should 
be considered in the presence of cold agglutinin testing by 
including RBCs of different ABO groups and with varying 
amounts of H and I antigens. The antibody reacts more avidly 
with samples with enhanced I and H antigens such as group 
A2 and O RBCs, and should be most compatible with group A1 
and cord RBCs (having the least quantity of H and I antigen).
Molecular Basis
The FUT1 and FUT2 genes are closely linked and located 
on chromosome 19q13.3.8 In genomic sequence annotation 
release 107 from March 2015, the two genes are in opposite 
orientation with a distance of approximately 42,000 base pairs 
(bp) (Fig. 2). The SEC1P pseudogene upstream of FUT2 is 
highly homologous to the FUT genes but inactive because of 
deletions and mutations in the coding region. The molecular 
cloning and characterization of the FUT1 gene was first 
reported in 1990.2 The genomic structure of the FUT1 gene 
includes four exons spanning a region of approximately 7800 
bp. The entire coding sequence (CDS) is located within exon 
4 and encodes a 365–amino acid polypeptide.2 The encoded 
α2FucT1 enzyme adds α-L-fucose to the type 2 precursor 
chain on RBCs and other cells. The 5 -́untranslated region with 
exons 1–3 contains two distinct promoters with transcription 
start sites upstream of exon 1 and exon 2.9 Alternative splicing 
of the FUT1 transcripts was reported for different cell types. 
Recently, it was shown that the transcription factor c-jun 
binds to an AP-1 site in the promoter region upstream of exon 
1 and thereby activates transcription of the FUT1 gene.10 The 
FUT2 gene has only two exons, and the entire CDS is in exon 
2. The encoded α2FucT2 enzyme adds α-L-fucose to the type 
1 precursor chain in secretions.3 Two transcript variants with 
an upstream and a downstream translation initiation site 
encode a 343– and a 332–amino acid protein, respectively. 
The smaller protein is considered to be the active enzyme. This 
transcriptional regulation by c-jun was not found for the FUT2 
gene.10
At least one functioning copy of FUT1 needs to be present 
(H/H or H/h) for H to be expressed on RBCs. If both copies 
of FUT1 are inactive (h/h), the Bombay phenotype (Oh) 
results, and there is no expression of A, B, or H antigens on 
the RBCs. The inactive null alleles of FUT1 (FUT1*01N) are 
characterized by nonsense mutations causing a stop codon and 
a truncated protein or by missense mutations causing a single 
amino acid exchange in the catalytic domain of the enzyme 
(Table 1).11,12 Homozygosity or compound heterozygosity for 
null alleles leads to the h/h phenotype, which is characterized 
by absence of a functional fucosyltransferase adding fucose 
to the precursor chain type 1 on RBCs. Many missense 
cen
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Fig. 2 Gene map of the chromosome 19q13.3 region from centromer 
(cen; left) to telomer (ter; right) including the SEC1P, CA11, NTN5, 
FUT2, MAMSTR, RASIP1, IZUM01, FUT1 and FGF21 genes 
according to the National Center for Biotechnology Information 
(NCBI) genome database annotation release 107 (March 2015). 
The genomic organization of FUT1 and FUT2 indicates that the 
coding sequence (CDS; dark gray box) of each gene is located 
within one exon (exon 4 of FUT1 and exon 2 of FUT2).
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mutations of FUT1 (FUT1*01W) have been described (Table 
2), leading to a weak expression of H on RBCs typical for the 
para-Bombay phenotype (H+W).11,12
The FUT2 gene encodes α2FucT2, which synthesizes the 
H antigen found in body fluids, and is associated with a secretor 
(Se) status. Homozygosity or compound heterozygosity for 
null alleles is associated with the nonsecretor (se) status. In 
Europeans, the 428G>A nonsense mutation (Trp143ter) is the 
most common cause of the nonsecretor status. All other null 
alleles and FUT2 gene deletions are rare variants (Table 3).11,12 
Because of the sequence homology with SEC1P, unbalanced 
recombination leading to SEC1P-FUT2 hybrid genes or FUT2 
gene deletions have been reported as the molecular basis of the 
nonsecretor status.13,14 Additionally, nonsecretors express only 
the Lea antigen of the Lewis blood group system because the 
α1,3/4-fucosyltranferase encoded by the FUT3 gene uses the 
type 1 precursor. In secretors, the type 1 precursor carries the 
H antigen, and the carbohydrate structure can be converted 
to A or B blood group antigens as well as to the Leb antigen. 
Interestingly, FUT2 mutations leading to an inefficient 
α2FucT2 enzyme such as 385A>T (Ile129Phe) are associated 
with the Leab phenotype because less H type 1 results in less 
Leb, and the FUT3 enzyme more efficiently converts type 1 
precursor to Lea.15
In summary, for the genotype–phenotype correlation 
in the H blood group system, it is important to consider the 
genotype of both genes, FUT1 and FUT2. For the classic 
Table 1. Null alleles of the FUT1 gene leading to a lack of 






change Type of mutation Reference
FUT1*01N.01 422G>A Trp141Ter Nonsense 27
FUT1*01N.02 461A>G Tyr154Cys Missense 19, 28
FUT1*01N.03 462C>A Tyr154Ter Nonsense 29
FUT1*01N.04 513G>C Trp171Cys Missense 28
FUT1*01N.05 538C>T Gln180Ter Nonsense 27
FUT1*01N.06 547_548delAG 183fs Frameshift 20
FUT1*01N.07 586C>T Gln196Ter Nonsense 30
FUT1*01N.08 695G>A Trp232Ter Nonsense 31
FUT1*01N.09 725T>G Leu242Arg Missense 19, 32
FUT1*01N.10 776T>A Val259Glu Missense 28
FUT1*01N.11 785G>A; 786C>A Ser262Lys Missense 33
FUT1*01N.12 826C>T Gln276Ter Nonsense 10
FUT1*01N.13 880_882delTT 294fs Frameshift 20
FUT1*01N.14 944C>T Ala315Val Missense 28
FUT1*01N.15 948C>G Tyr316Ter Nonsense 10
FUT1*01N.16 980A>C Asn327Thr Missense 34
FUT1*01N.17 1047G>C Trp349Cys Missense 28
FUT1*01N.18 684G>A Met228Ile Missense 12
FUT1*01N.19 694T>C Trp232Pro Missense 12













ISBT = International Society of Blood Transfusion; del = deletion.
Table 2. Missense mutations of the FUT1 gene leading to a weak 
expression of H antigens on red blood cells




Amino acid  
change Reference
FUT1*01W.01 293C>T Thr98Met 37
FUT1*01W.02 328G>A Ala110Thr 30
FUT1*01W.03 349C>T His117Tyr 19
FUT1*01W.04 442G>T Asp148Tyr 31
FUT1*01W.05.01 460T>C Tyr154His 20, 31
FUT1*01W.05.02 460T>C; 1042G>A Tyr154His; 
Glu348Lys
31
FUT1*01W.07 491T>A Leu164His 10
FUT1*01W.08 522C>A Phe174Leu 38, 39
FUT1*01W.09 658C>T Arg220Cys 20, 39, 40
FUT1*01W.10 659G>A Arg220His 12, 39
FUT1*01W.11 661C>T Arg221Cys 41
FUT1*01W.12 682A>G Met228Val 42, 43
FUT1*01W.13 689A>C Gln230Pro 27
FUT1*01W.14 721T>C Tyr241His 31
FUT1*01W.15 801G>C Trp267Cys 44
FUT1*01W.16 801G>T Trp267Cys 44
FUT1*01W.17 832G>A Asp278Asn 44
FUT1*01W.19 917C>T Thr306Ile 27
FUT1*01W.21 235G>C Gly79Arg 40
FUT1*01W.22 991C>A Pro331Thr 45
FUT1*01W.23 424C>T Arg142Trp 46
FUT1*01W.24 649G>T Val217Phe 35
FUT1*01W.25 235G>C Gly79Arg 40
FUT1*01W.26 545G>A Arg182His 11, 12
FUT1*01W.27 958G>A Gly320Arg 11, 12
FUT1*01W.28 896A>C Gln299Pro 47
FUT1*01W.29 655G>C Val219Leu 48
FUT1*02W.01 269G>T Gly90Val 12
FUT1*02W.02 371T>G Phe124Cys 12







ISBT = International Society of Blood Transfusion; del = deletion.
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Bombay phenotype (Oh), both genes are inactive (genotype: 
h/h and se/se) and no H antigens are expressed on RBCs or in 
secretions. For the para-Bombay phenotype (H+W), two types 
can be distinguished: 
(1) lack of H on RBCs caused by inactive FUT1 null alleles 
(FUT1*01N) and presence of H in secretions caused by an 
active FUT2 gene (Se);  
(2) weak expression of H on RBCs caused by FUT1 
mutant alleles (FUT1*01M) encoding weakly active 
fucosyltransferases in combination with active or inactive 
FUT2 (Se or se).
Particularly for the type 1 para-Bombay phenotype, it 
is important to note that the H antigens produced by FUT2 
in secretions can be absorbed by RBCs. The H+W cells 
can be converted to A+W or B+W when the corresponding 
glycosyltransferases are encoded by the ABO locus.
Populations
The Bombay phenotype is almost unique to Indian 
ethnic groups, with a prevalence of about 0.7 percent, and is 
rare in most populations. The greater numbers of cases are 
situated in the southern states of India (Table 4).16 Further 
studies published in 2007 of the Bhuyan tribal population of 
Orissa, India, revealed the average prevalence of the Bombay 
phenotype to be 1 in 278.17 The prevalence therefore varies 
depending on the number of global migrants originating from 
these regions. A study on people living on Reunion Island 
(east of Madagascar) revealed a second geographic “hot spot” 
of the Oh phenotype with a high prevalence (1:1000).18,19 
Interestingly, although the largest series of H– phenotypes in 
Bombay and Natal were of Indian ethnicity, 85 percent of the 
Reunion Oh phenotype were of European descent (mostly of 
French origin). The Oh and para-Bombay phenotype has also 
been found in other ethnic groups such as Taiwanese (1:8000), 
Hong Kong Chinese (1:15,620), and those of European origin 
(1:1,000,000).20,21
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FUT2*01N.03 569G>A Arg190His Missense 50
FUT2*01N.04 571C>T Arg191Ter Nonsense 52
FUT2*01N.05 628C>T Arg210Ter Nonsense 14
FUT2*01N.06 658C>T Arg220Ter Nonsense 53
FUT2*01N.07 664C>T Arg222Cys Missense 52
FUT2*01N.08 685_686delGT 230fs234Ter Frameshift
FUT2*01N.09 688_690delGTC del230Val In-frame del 54, 55







FUT2*01N.11 778delC 259fs275Ter Frameshift 56
FUT2*01N.12 849G>A Trp283Ter Nonsense 57
FUT2*01N.13 868G>A Gly290Arg Missense 52
FUT2*01N.14 950C>T Pro317Leu Missense 50
FUT2*01N.15 302C>T Pro101Leu Missense 58
FUT2*01N.16 960A>G Gly247Ser Missense 45, 51, 
52
FUT2*01N.17 412G>A Gly138Ser Missense 45
FUT2*01N.18 818C>A Thr273Asn Missense 59
FUT2*0N.01 Gene deletion Deletion 19, 32, 
60
FUT2*0N.02 Coding region 
deleted 
Deletion 61
FUT2*0N.03 Fusion gene 1 
between FUT2  
and SEC1P 
Recombination 14, 50, 
62
FUT”*0N.04 Fusion gene 2 
between FUT2  
and SEC1P
Recombination 50
ISBT = International Society of Blood Transfusion; del = deletion.
Table 4. Distribution of Oh phenotype cases reported from 
different states of India
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In summary, FUT1 mutant alleles are rare, and their 
geographic distribution varies greatly. The frequency of 
FUT2 null alleles may be 20 percent or higher. A linkage 
disequilibrium of mutations in FUT1 and FUT2 was observed, 
and is attributable to the close proximity of both genes on 
chromosome 19q13.3.19 Individuals of particular ethnic groups 
have a unique set of mutations: in India, FUT1 725T>G with 
FUT2 deletion; on Reunion Island (Caucasian), FUT1 349C>T 
with FUT2 428G>A.
Clinical Significance
Anti-H in Oh individuals can cause severe hemolytic 
transfusion reactions with intravascular hemolysis. Anti-H 
and anti-IH, which are sometimes found in the serum of A1 
people, although generally not considered clinically significant, 
have been reported to cause hemolytic transfusion reactions 
when the antibodies are demonstrable and reactive by the 
IAT.22,23 Such patients should receive cross-match compatible 
A1 (type-specific) RBC concentrates. 
Theoretically, anti-H during pregnancy could cause 
hemolytic disease of the fetus and newborn (HDFN) in a non-
Oh fetus. In practice, however, cases of HDFN have not been 
described. In an evaluation performed in South Africa of 21 Oh 
pregnancies/births, only one baby required transfusion, and 
none were seen to have HDFN.
The function of the H antigen, besides being a precursor for 
the synthesis of ABO blood group antigens, is not well known; 
although, it may be involved in cell adhesion. Individuals 
lacking H do not seem to suffer any ill effects. 
The leukocyte adhesion deficiency II (LADII) is a rare 
inherited primary immunodeficiency disorder resulting from 
a defect in fucose metabolism. Patients with this disorder are 
unable to fucosylate glycoproteins, including the H blood group 
polysaccharide and, therefore, present serologically as Oh blood 
group. This disorder is characterized by recurrent infections 
in the patients, persistent leucocytosis, and severe mental and 
growth retardation.24 Treatment with oral L-fucose reverses 
most of the symptoms in these patients, but has no effect on 
true Oh individuals.
Recent reports indicate that FUT1 significantly contributes 
to angiogenesis in the context of rheumatoid arthritis and 
ovarian cancer.9,25,26 It is speculated that the higher degree of 
fucosylation of molecules important for cell adhesion, such as 
the Lewis antigens, promotes inflammatory and angiogenic 
mechanisms.
Summary
The H blood group system currently consists of the antigen 
H. Complete lack of H results in the Bombay (Oh) phenotype 
and weak expression of H is known as the para-Bombay 
phenotype. There are a number of genetic mutations that have 
been found to be responsible for the Oh (FUT1*01N alleles) 
and the para-Bombay (FUT1*01W alleles) types. The FUT1 
locus and FUT2 locus are closely linked, which can result in 
individuals who may have weak expression or no H expressed 
on their RBCs, although H may be found in secretions. The H 
antigen is the precursor for the ABO blood group antigens, and 
therefore plays a significant role in the serologic blood type 
of an individual. As with ABO, the antibodies produced by 
individuals who lack H can cause severe hemolytic reactions, 
although there have not been many reported cases of obstetric 
significance.
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